These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33076510)

  • 21. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
    Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
    Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.
    Weda M; Zanen P; de Boer AH; Gjaltema D; Ajaoud A; Barends DM; Frijlink HW
    Int J Pharm; 2002 Dec; 249(1-2):247-55. PubMed ID: 12433452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.
    Taki M; Marriott C; Zeng XM; Martin GP
    Int J Pharm; 2010 Mar; 388(1-2):40-51. PubMed ID: 20026261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.
    Dunbar C; Scheuch G; Sommerer K; DeLong M; Verma A; Batycky R
    Int J Pharm; 2002 Oct; 245(1-2):179-89. PubMed ID: 12270254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2019 Jan; 20(2):57. PubMed ID: 30623259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.
    Kou X; Wereley ST; Heng PW; Chan LW; Carvajal MT
    Int J Pharm; 2016 Dec; 514(2):445-455. PubMed ID: 27497998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel aerodynamic sizing method for pharmaceutical aerosols using image-based analysis of settling velocities.
    Fishler R; Sznitman J
    Inhalation; 2017 Jun; 11(3):21-25. PubMed ID: 28690715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals.
    Tougas TP; Goodey AP; Hardwell G; Mitchell J; Lyapustina S
    AAPS PharmSciTech; 2017 Feb; 18(2):451-461. PubMed ID: 27068528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of dry powder inhalers.
    Chougule MB; Padhi BK; Jinturkar KA; Misra A
    Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.
    Kadota K; Yanagawa Y; Tachikawa T; Deki Y; Uchiyama H; Shirakawa Y; Tozuka Y
    Int J Pharm; 2019 Jan; 555():280-290. PubMed ID: 30471373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry powder inhaler device influence on carrier particle performance.
    Donovan MJ; Kim SH; Raman V; Smyth HD
    J Pharm Sci; 2012 Mar; 101(3):1097-107. PubMed ID: 22095397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Grimm 1.108 and 1.109 portable aerosol spectrometer to the TSI 3321 aerodynamic particle sizer for dry particles.
    Peters TM; Ott D; O'Shaughnessy PT
    Ann Occup Hyg; 2006 Nov; 50(8):843-50. PubMed ID: 17041244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T; Misra A
    Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.